Medical Devices: Page 168
-
Moody's boosts growth forecast for US medical device industry
The ramped up prediction comes in response to strong sales of relatively new, high-margin products at companies such as Edwards Lifesciences and Medtronic.
By Nick Paul Taylor • Nov. 1, 2018 -
NuVasive CEO says spine industry poised to consolidate
The spinal device maker said it is moving from belt-tightening to investment mode to take advantage of improving market conditions.
By Susan Kelly • Oct. 31, 2018 -
Explore the Trendline➔
Sitthiphong via Getty Images
TrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Baxter posts 'frankly disappointing' sales as hurricane aftereffects linger
"It is now becoming clear that the market dynamics have fundamentally shifted, at least in the near- to mid-term," Baxter CEO José Almeida said on the quarterly conference call with investors.
By Nick Paul Taylor • Oct. 31, 2018 -
Baxter earns CE mark for new renal replacement system
Launch of the PrisMax device builds on the company's Prismaflex technology for filtering the blood of critically ill patients, and is a key event for the company's acute therapies business.
By Susan Kelly • Oct. 30, 2018 -
Genentech releases more data on refillable eye implant
Study results showed that vision and anatomical outcomes in wet AMD patients who received the device, and dosed every six months or longer, were comparable to ranibizumab dosed every four weeks.
By Susan Kelly • Oct. 30, 2018 -
Getty Images
Leerink predicts Inspire to clear coverage blockade, quickly grow sleep apnea sales
The upbeat estimates assume another major insurer will cover the implant in the next 18 months.
By Nick Paul Taylor • Oct. 30, 2018 -
Adobe Stock
Look out device makers — Amazon set to sell glucose monitors, blood pressure cuffs
The products will be sold under the brand name Choice through a partnership with Arcadia Group, a consultancy firm with a history of partnering with big brand retailers like Walmart.
By Samantha Liss • Oct. 29, 2018 -
Deep Dive
5 sticking points in the EU medical device reg transition
Brexit and notified body capacity are among the uncertainties, as many in the medtech sector are uninformed.
By Meg Bryant • Oct. 29, 2018 -
FDA panel to review first-of-a-kind heart failure device
The advisory group will vote on Impulse Dynamics' premarket application for a cardiac contractility modulation device to treat class III heart failure at a December meeting.
By Susan Kelly • Oct. 29, 2018 -
Drug-delivery device developer snags Sanofi as investor
Cincinnati, Ohio-based Enable Injections is developing a wearable device for subcutaneous delivery of biologics and other therapeutics.
By Susan Kelly • Oct. 29, 2018 -
Cleveland Clinic pegs 10 potentially game-changing medical innovations
Alternative pain therapies to fight the opioid epidemic topped the list. Others include AI, new guidelines for an expanded stroke treatment window, advances in immunotherapy for cancer and 3D printed, patient-specific products.
By Meg Bryant • Oct. 26, 2018 -
Getty Images
Stryker touts benefits of Mako robot on knee outcomes, costs
The medical device maker said robot-assisted procedures are gaining traction in orthopaedic surgery, contributing to an 8% growth rate in sales of the company’s knee replacements in the third quarter.
By Susan Kelly • Oct. 26, 2018 -
Zimmer profit rises 64% in Q3, driven by knee, hip products
Although implant sales were clear profit growth drivers, Zimmer saw small but marked increases across each of its portfolios.
By Rebecca Pifer • Oct. 26, 2018 -
ResMed posts double-digit growth as software sales soar
Results were burnished by the acquisition of home health software provider HEALTHCAREfirst.
By Nick Paul Taylor • Oct. 26, 2018 -
Elizabeth Regan/BioPharma Dive
Novarad augmented reality system for surgery clears FDA
The OpenSight system is designed for use with Microsoft HoloLens technology.
By Meg Bryant • Oct. 25, 2018 -
Getty Images
Medtronic's dose-controlling app for pain pump gets FDA nod
The technology enables users to deliver doses on demand to cope with breakthrough pain.
By Nick Paul Taylor • Oct. 25, 2018 -
Adverse events prompt FDA to advise monitoring of Alcon implants
For now, the FDA says the problem looks to be limited to Alcon's implant. Glaukos markets a rival iStent device and saw its stock price increase by 40% when Alcon withdrew its stent.
By Nick Paul Taylor • Oct. 25, 2018 -
Boston Scientific posts strong Q3 with 8.7% sales growth
Coming off a legal win in a patent battle with Edwards, the CEO held his cards close to the vest on next steps on the earnings call.
By David Lim • Updated Oct. 25, 2018 -
Edwards Lifesciences Q3 sales up 10%
Sales of transcatheter aortic valves implanted without open heart surgery rose 16% to $558 million, even as the company's market share outside the U.S. declined slightly and royalty revenue fell.
By Susan Kelly • Oct. 24, 2018 -
MedImmune
LabCorp blames data breach, hurricane for substandard Q3
The diagnostics branch was "particularly disappointing," said chairman and CEO Dave King.
By Rebecca Pifer • Oct. 24, 2018 -
Medtronic's low-profile thoracic endograft gets FDA nod
By expanding TEVAR to patients with a broader range of anatomies, Medtronic could gain an edge over rivals Bolton Medical, Cook Medical and Gore Medical.
By Nick Paul Taylor • Oct. 24, 2018 -
Stryker closes Invuity acquisition
Invuity's CEO called out "a lack of strategic organizational alignment in our sales and marketing efforts" during its Q2 earnings call, something that Stryker may be well positioned to help fix.
By David Lim • Oct. 23, 2018 -
Heater-cooler device redesigned to limit infections: FDA
The LivaNova system used to warm and cool patients during open heart surgery has been the subject of a recall and a number of federal safety communications related to nontuberculous mycobacteria infections.
By Susan Kelly • Oct. 22, 2018 -
Jacob Bell / BioPharma Dive
Abbott HeartMate 3 gets OK as transplant alternative
The Momentum 3 results could help Abbott gain market share from competitor Medtronic's ventricular assist device called HeartWare, acquired in 2016, according to analysts.
By Susan Kelly • Oct. 22, 2018 -
Stryker asks to extend anti-trust deadline for K2M deal
The ask comes as the companies face two shareholder lawsuits challenging the merger on the grounds that K2M failed to disclose financial projections needed to fairly assess the transaction.
By Susan Kelly • Oct. 22, 2018
Previous
